Evidence map›Paper›PMID 36079565›Full record

ReviewPlants (Basel, Switzerland)2022

Mostafa Amani Machiani, Abdollah Javanmard, Reyhaneh Habibi Machiani, Amir Sadeghpour

Open access · goldAbstract readReview
In one paragraph

Review in Plants (Basel, Switzerland), 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed
12.4field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed, 68 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Review
  9. Article
  10. Improvement ofFrontiers in plant science · 2024
    Article
  11. Article
  12. The Effects ofPlants (Basel, Switzerland) · 2023
    Article
  13. Review
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 2 countries.

Mostafa Amani MachianiDepartment of Plant Production and Genetics, Faculty of Agriculture, University of Maragheh, P.O. Box 55136-553, Maragheh 83111-55181, Iran.ORCID 0000-0001-6145-1049
Abdollah JavanmardDepartment of Plant Production and Genetics, Faculty of Agriculture, University of Maragheh, P.O. Box 55136-553, Maragheh 83111-55181, Iran.
Reyhaneh Habibi MachianiDepartment of Plant Production and Genetics, Faculty of Agriculture, University of Maragheh, P.O. Box 55136-553, Maragheh 83111-55181, Iran.
Amir SadeghpourCrop, Soil and Environment Program, School of Agricultural Sciences, Southern Illinois, University of Carbondale, College of Science, Carbondale, IL 62901, USA.
University of Maragheh · IRSouthern Illinois University Carbondale · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Medicinal and aromatic plants (MAPs) are able to synthesize a diverse group of secondary metabolites (SMs) such as terpenoids or terpenes, steroids, phenolics, and alkaloids with a broad range of therapeutic and pharmacological potentials. Extensive use of MAPs in various industries makes it important to re-evaluate their research, development, production, and use. In intensive agricultural systems, increasing plant productivity is highly dependent on the application of chemical inputs. Extreme use of chemical or synthetic fertilizers, especially higher doses of N fertilization, decrease the yield of bioactive compounds in MAPs. The plant-soil microbial interaction is an eco-friendly strategy to decrease the demand of chemical fertilizers.

Indexed as

alkaloidsArbuscular mycorrhizal fungiessential oilsecondary metabolitesterpenes

Identifiers

PMID36079565
PMCPMC9460575
OpenAlexW4292879249

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.